+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797



Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797



International Journal of Pharmaceutical Compounding 12(2): 136-144



United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations pertains to all preadministration manipulations and procedures involved in the preparation of sterile compounds for application, implantation, infusion, inhalation, injection, insertion, instillation, or irrigation, including preparation, storage and transportation. The chapter does not pertain to actual clinical administration of compounded sterile preparations to patients. The intent of Chapter 797 is simply to prevent patient harm and fatalities that may result from nonsterility , excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Because the achievement of sterility requires that facilities meet minimum cleanliness standards, that personnel be trained adequately and undergo periodic testing and training in sterilization techniques, and that appropriate principles and practices be appied to sustain solution stability, compliance with Chapter 797, and those that have already met the new standards seem to support them strongly. A number of significant changes have been made to Chapter 797, and this article discusses these changes.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051761085

Download citation: RISBibTeXText

PMID: 23969607


Related references

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 11. International Journal of Pharmaceutical Compounding 13(1): 56-62, 2009

Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13. International Journal of Pharmaceutical Compounding 13(3): 234-238, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12. International Journal of Pharmaceutical Compounding 13(2): 146-150, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating. International Journal of Pharmaceutical Compounding 12(4): 344-353, 2008

Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2. International Journal of Pharmaceutical Compounding 11(4): 313-323, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued). International Journal of Pharmaceutical Compounding 13(4): 322-329, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 16: suggested standard operating procedures. International Journal of Pharmaceutical Compounding 13(6): 546-553, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing. International Journal of Pharmaceutical Compounding 11(5): 420-426, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics. International Journal of Pharmaceutical Compounding 11(6): 492-499, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use. International Journal of Pharmaceutical Compounding 12(3): 252-257, 2008

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 20: patient or caregiver training, patient monitoring and adverse events reporting, and quality-assurance program. International Journal of Pharmaceutical Compounding 14(4): 328-331, 2010

Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4. International Journal of Pharmaceutical Compounding 16(1): 64-68, 2012

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations. International Journal of Pharmaceutical Compounding 12(5): 440-443, 2008

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations. International Journal of Pharmaceutical Compounding 14(1): 60-64, 2010